Investing.com -- MannKind Corporation (NASDAQ:MNKD) shares fell 37% Wednesday after partner United Therapeutics unveiled a soft-mist inhaler that will compete with dry powder inhalation therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results